To synthesize recent advancements in tuberculosis immunotherapy, focusing on applications, challenges, and prospective directions.
Approach:
Immunotherapy Overview: The review summarizes the immune response to TB, evaluates progress in various immunotherapy modalities, and analyzes clinical trials and challenges.
Key Findings:
Immunotherapy has potential to address multidrug-resistant tuberculosis (MDR-TB) and reduce side effects of traditional treatments.
Key strategies include identifying novel antigens, optimizing immune checkpoint modulation, and combining therapies.
Advancements in single-cell sequencing and bioengineering are expected to accelerate immunotherapy development.
Interpretation:
Immunotherapy offers multifaceted strategies to enhance TB treatment, particularly for drug-resistant cases.
Limitations:
Long-standing neglect in TB immunology research has hindered progress.
Challenges include immune exhaustion and antigen heterogeneity.
Conclusion:
Immunotherapy represents a promising adjunct to conventional TB treatment, with ongoing research needed to fully realize its potential.
